Exploring Tisotumab Vedotin in Frontline Cervical Cancer
Time: 9:30 am
day: Day Two
Details:
- Showcasing Tisotumab Vedotin data from the innovaTV 204 clinical trial
- Discussing emerging Tisotumab Vedotin data as a frontline treatment
- Exploring how Tisotumab Vedotin has the possibility as a frontline treatment for cervical cancer
